Veracyte, Inc. (VCYT)
44.06
+2.59
(+6.25%)
USD |
NASDAQ |
Aug 25, 16:00
44.06
0.00 (0.00%)
After-Hours: 19:59
Veracyte EPS Diluted (Quarterly) : 0.3106 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3106 |
| March 31, 2026 | 0.353 |
| December 31, 2025 | 0.5056 |
| September 30, 2025 | 0.2401 |
| June 30, 2025 | -0.0125 |
| March 31, 2025 | 0.088 |
| December 31, 2024 | 0.064 |
| September 30, 2024 | 0.1931 |
| June 30, 2024 | 0.0743 |
| March 31, 2024 | -0.0249 |
| December 31, 2023 | -0.387 |
| September 30, 2023 | -0.4068 |
| June 30, 2023 | -0.1159 |
| March 31, 2023 | -0.1121 |
| December 31, 2022 | -0.0535 |
| September 30, 2022 | -0.1217 |
| June 30, 2022 | -0.1334 |
| March 31, 2022 | -0.203 |
| December 31, 2021 | -0.1482 |
| September 30, 2021 | -0.2026 |
| June 30, 2021 | -0.1343 |
| March 31, 2021 | -0.6611 |
| December 31, 2020 | -0.1386 |
| September 30, 2020 | -0.0752 |
| June 30, 2020 | -0.2196 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2353 |
| December 31, 2019 | -0.1519 |
| September 30, 2019 | -0.015 |
| June 30, 2019 | -0.0547 |
| March 31, 2019 | -0.0466 |
| December 31, 2018 | -0.0762 |
| September 30, 2018 | -0.1157 |
| June 30, 2018 | -0.1821 |
| March 31, 2018 | -0.2678 |
| December 31, 2017 | -0.2478 |
| September 30, 2017 | -0.21 |
| June 30, 2017 | -0.22 |
| March 31, 2017 | -0.24 |
| December 31, 2016 | -0.14 |
| September 30, 2016 | -0.20 |
| June 30, 2016 | -0.40 |
| March 31, 2016 | -0.36 |
| December 31, 2015 | -0.29 |
| September 30, 2015 | -0.32 |
| June 30, 2015 | -0.35 |
| March 31, 2015 | -0.34 |
| December 31, 2014 | -0.36 |
| September 30, 2014 | -0.37 |
| June 30, 2014 | -0.31 |
| March 31, 2014 | -0.32 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Globus Medical, Inc. | 1.103 |
| Recursion Pharmaceuticals, Inc. | -0.246 |
| Anika Therapeutics, Inc. | 0.2412 |
| Perspective Therapeutics, Inc. | -0.222 |
| Teleflex, Inc. | 2.283 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 25.49M |
| Revenue (Quarterly) | 150.32M |
| Total Expenses (Quarterly) | 124.83M |
| Enterprise Value | 2.888B |
| Gross Profit Margin (Quarterly) | 71.93% |
| Profit Margin (Quarterly) | 16.96% |
| Earnings Yield | 3.20% |
| Operating Earnings Yield | 2.71% |
| Normalized Earnings Yield | 2.928 |